| "Regenerative Medicine" journal: Leading journal in the regenerative medicine sector includes stem cells and tissue engineering. |
| Abcam: Stem Cells: Antibodies, markers, reagents and recent reviews of their applications, links to conferences. Online catalog and purchase available from Cambridge, England and Massachusetts. |
| Axordia: Axordia is one of the UK’s leading human embryonic stem cell (hESC) companies. It has a unique portfolio of patent protected technologies and proprietary materials - GMP derived hESC lines; the capacity to produce key cell line derivatives, including a patent protected endovascular line with powerful potential; RNA interference (RNAi); Wnt and Notch signalling; a suite of hESC biomarkers. |
| BeFutur Biotechnologies: Company conducts research using autologous human cells in a serum free medium to treat incurable diseases. The results propose possible new treatments for regeneration of diseased tissues. Based in Geneva, Switzerland. |
| Capsant Neurotechnologies: The company's primary drug evaluation focus is in the field of chronic and acute neurodegenerative diseases. Capsant has pioneered and developed a number of in-vitro, 3-dimentional tissue-based (organotypic) models that closely mimic many of the characteristics of major CNS disorders such as stroke, Alzheimer's Disease, MS and epilepsy. |
| CellResearch Corp. Pte. Ltd.: Inventors of ethical umbilical cord mesenchymal and epithelial progenitor cell lines targeted at regenerative medicine. Also offering primary skin cell culture systems, both normal and diseased, and customised research in Singapore. |
| Cells Limited: Offers ISO 17025 compliant storage of stem cells derived from the umbilical cord blood or bone marrow, and associated testing in Harrow, England. |
| CellTran: CellTran has developed advanced polymer surface technology and has optimised methods for the culture of autologous and allogeneic cells. |
| Chris Mason: Consultant to the global stem cell, tissue engineering and regenerative medicine industry. |
| CXR Biosciences: Drug discovery and development tools including the deployment of stem cell technologies |
| Embryotech: Medical Center of Cell and Tissue Therapy Embryotech. The Centre deals cell therapy, cryobiology and cell biology. cryopreservation of stem cells and specialized cells clinic providing a range of laboratory diagnostics for the purpose of conducting an integrated estimation of patient"s condition as well as individual selection of cell transplants. |
| EpiStem: Epithelial Tissue, Tumour and Adult Stem Cell responses - pre-clinical solutions to assist development of novel therapies for proliferative disease. |
| Genzyme Biosurgery: Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products including cell and tissue-engineered therapies e.g. Carticel + Epicel |
| Geron Corporation: Discovers and develops therapeutic and diagnostic products, as well as projects for cancer, skin aging, atherosclerosis, osteoporosis and macular degeneration. Headquartered in Menlo Park, California. (Nasdaq: GERN) |
| InbioBank: Non profit, adult stem cell bank that produces stem and primary cells at cGMP quality standards for cellular therapy and basic research. |
| Intercytex Ltd.: Biotech company in the field of cell therapies including skin and hair regeneration products. Currently in clinical phase 3 trials in the USA, Canada and UK, headquartered in Cambridge, England. |
| Isolagen: Isolagen specialises in the development and commercialisation of its autologous cellular system (ACS) technology. |
| NovaThera: REgenerative medicine company with interests in both tissue engineering scaffolds and human embryonic stem cells. Particularly interested in lung tissue. |
| Odontis Ltd.: Formed in 2002 to develop new in vivo tissue engineering technology for damaged or missing teeth, including growth of patient-matched dental implants. Contacts and introduction to research at Guy’s Hospital, London, UK. |
| Plasticell: Plasticell is a privately held biotechnology company using novel stem cell culture and drug discovery platforms to produce regenerative small molecule drugs. |
| Pluristem Life Systems Inc.: Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel. |
| ReNeuron Ltd.: Developing somatic transplantation technology for diabetes, neuronal degeneration and therapy for brain damage including stroke, Parkinson's disease, Alzheimer's and Huntington's disease. Overview of company in Guildford, England. |
| Stem Cell Hope: Facilitates umbilical cord cell therapy and treatment by providing communication, scheduling, and other arrangement assistance to those who desire to try this treatment. |
| Stem Cell Sciences: Stem Cell Sciences' principal objective is to be the first company to deliver clinical benefit from an embryonic stem cell-derived cell therapy. This requires multiple technologies and a globally integrated initiative. |
| Stem-cell-companies.com: Directory of companies involved in stem cell research and development. |
| Stemcell Technologies: Specialist contract research organaization, offering kits for selection and enrichment from embryonic, epithelial hematopoietic or neural origin, and cloning of either hybridomas or non-adherent stably transfected cells. International laboratories headquartered from the USA. |
| Stemride International Ltd.: Offers lines of normal human embryonic stem cells, and genetically abnormal variants to scientists and researchers. with sub-licensing to commercial and scientific institutions from London, UK. |
| TheraVitae Co.,Ltd.: Developing therapy by the transplantation of the patient's own cell-line after isolation and processing in vitro, to replace, repair or enhance the function of damaged tissues. Clinical trials based in Bangkok, Thailand and Kiryat Weizmann, Israel. |
| TriStem Corp.: Research and development of retrodifferentiation technology, used to create stem cells from mature adult cells. Includes technological and corporate overview, with FAQ and contacts in London, UK. |
| Vet-Stem, Inc.: Offers isolation and concentration from a sample of fat for treatment of injuries to tendons, ligaments, and fractures in performance horses. Includes explanation, case studies, news, description of services for horse owners and veterinarians, with contacts in Poway, California. |
| VetCell Bioscience: VetCell BioScience investigates, develops and commercialises new technologies for veterinary use. The company focuses on cellular therapeutics for the regeneration and functional restoration of damaged and diseased tissue. |
| ViaCell, Inc.: Developing therapies for the treatment of bone defects and myocardial regeneration, utilizing somatic stem cells isolated from cord blood. Based in Cambridge, Massachusetts. |
| XYClone Zona Laser Drill: Offers stem cell researchers a method of opening the zona for insertion or withdrawal of genetic material. From Hamilton Thorne Biosciences Inc., Beverly, Massachusetts |
Classical
